NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

CureVac NV (XETRA: 5CV)

 
5CV Technical Analysis
4
As on 7th May 2025 5CV SHARE Price closed @ 2.96 and we RECOMMEND Sell for LONG-TERM with Stoploss of 3.25 & Strong Sell for SHORT-TERM with Stoploss of 4.06 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

5CVSHARE Price

Open 3.00 Change Price %
High 3.01 1 Day -0.06 -1.99
Low 2.92 1 Week 0.01 0.34
Close 2.96 1 Month 0.31 11.70
Volume 77000 1 Year -2.13 -41.85
52 Week High 5.45 | 52 Week Low 2.11
 
XETRA Germany Most Active Stocks
LHAR 2.05 -20.23%
BBVA 5.00 -2.72%
BBVA 5.00 -2.72%
BBVA 5.00 -2.72%
BVBA 0.02 -60.00%
SNH 0.16 6.67%
SNH 0.16 6.67%
SNH 0.16 6.67%
AMMN 8500.00 1440578.00%
BCY 3.50 -1.69%
 
XETRA Germany Top Gainers Stocks
AMMN 8500.00 1440578.00%
PDA 2.73 196.74%
PDA 2.73 196.74%
PDA 2.73 196.74%
PDA 2.73 196.74%
PDA 2.73 196.74%
PDA 2.73 196.74%
PAG 0.02 100.00%
PAG 0.02 100.00%
PAG 0.02 100.00%
 
XETRA Germany Top Losers Stocks
F03 0.56 -99.14%
F03 0.56 -99.14%
F03 0.56 -99.14%
F03 0.56 -99.14%
IQL 0.02 -66.67%
IQL 0.02 -66.67%
EIN3 60.20 -63.95%
EIN3 60.20 -63.95%
EIN3 60.20 -63.95%
LEO 0.04 -63.64%
 
 
5CV
Daily Charts
5CV
Intraday Charts
Whats New @
Bazaartrend
5CV
Free Analysis
 
5CV Important Levels Intraday
RESISTANCE3.13
RESISTANCE3.08
RESISTANCE3.04
RESISTANCE3.01
SUPPORT2.91
SUPPORT2.88
SUPPORT2.84
SUPPORT2.79
 
5CV Forecast May 2025
4th UP Forecast7.99
3rd UP Forecast6.38
2nd UP Forecast5.38
1st UP Forecast4.38
1st DOWN Forecast1.54
2nd DOWN Forecast0.54
3rd DOWN Forecast-0.46
4th DOWN Forecast-2.07
 
5CV Weekly Forecast
4th UP Forecast3.75
3rd UP Forecast3.50
2nd UP Forecast3.34
1st UP Forecast3.18
1st DOWN Forecast2.74
2nd DOWN Forecast2.58
3rd DOWN Forecast2.42
4th DOWN Forecast2.17
 
5CV Forecast2025
4th UP Forecast10.11
3rd UP Forecast7.82
2nd UP Forecast6.4
1st UP Forecast4.98
1st DOWN Forecast0.94
2nd DOWN Forecast-0.48
3rd DOWN Forecast-1.9
4th DOWN Forecast-4.19
 
 
5CV Other Details
Segment EQ
Market Capital 6198986240.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
5CV Address
5CV
 
5CV Latest News
 
Your Comments and Response on CureVac NV
 
5CV Business Profile
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidate against COVID-19; CV7202, a prophylactic mRNA-based vaccine, which is in Phase 1 clinical trial for rabies virus glycoprotein; vaccine for lassa yellow fever; vaccine for respirational syncytial virus; CV7301, a second-generation lipid nanoparticle flu vaccine; and vaccines for rota, malaria, and universal influenza. The company also develops RNA-based cancer immunotherapies, including CV8102, which is in Phase 1 clinical trial for treating cutaneous melanoma and adenoidcystic carcinoma, as well as squamous cell cancer of skin, head, and neck; and CV9202 (BI 1361849), a self-adjuvanting mRNA vaccine that is in Phase 1 clinical trial for non-small cell lung cancer, as well as tumor associated antigens and shared neo-antigens. In addition, it is developing protein-based therapies for Cas9 gene-editing, ocular diseases, and lung respiratory diseases, as well as therapeutic antibodies. The company was founded in 2000 and is headquartered in Tübingen, Germany. Address: Friedrich-Miescher-Strasse 15, Tübingen, Germany, 72076
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service